TVAX Biomedical
Quick facts
Phase 2 pipeline
Phase 1 pipeline
- Cancer vaccine plus immune adjuvant
Combines cancer antigens with immune adjuvants to stimulate and enhance the body's immune response against tumor cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies